Ferric carboxymaltose
Injectafer (ferric carboxymaltose) is an unknown pharmaceutical. Ferric carboxymaltose was first approved as Injectafer on 2013-07-25.
Download report
Favorite
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
Injectafer
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Ferric carboxymaltose
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| INJECTAFER | American Regent | N-203565 RX | 2013-07-25 | 4 products, RLD, RS |
Labels
FDA
EMA
Brand Name | Status | Last Update |
|---|---|---|
| injectafer | New Drug Application | 2021-11-01 |
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
Expiration | Code | ||
|---|---|---|---|
FERRIC CARBOXYMALTOSE, INJECTAFER, AM REGENT | |||
| 2024-11-19 | NPP | ||
| 2024-04-28 | NS | ||
Patent Expiration
Patent | Expires | Flag | FDA Information |
|---|---|---|---|
| Ferric Carboxymaltose, Injectafer, Am Regent | |||
| 7754702 | 2028-02-15 | U-1432, U-2555, U-2556, U-2557, U-3312, U-3313, U-3314 | |
| 8895612 | 2027-01-08 | U-1620, U-3050, U-3051, U-3115, U-3116, U-3315, U-3316 | |
| 11433091 | 2027-01-08 | U-3435, U-3436, U-3437, U-3438 | |
| 11478502 | 2027-01-08 | U-3472, U-3473, U-3474 | |
| 7612109 | 2024-02-05 | DS, DP | |
| 9376505 | 2023-10-20 | DS, DP | |
| 11123321 | 2023-10-20 | DS, DP | U-2555, U-2557, U-3312, U-3313 |
| 11291645 | 2023-10-20 | DS, DP | U-3351, U-3352 |
| 11590097 | 2023-10-20 | DS, DP | U-3312, U-3313 |
ATC Codes
No data
HCPCS
Code | Description |
|---|---|
| J1439 | Injection, ferric carboxymaltose, 1 mg |
Clinical
Clinical Trials
151 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Iron-deficiency anemia | D018798 | HP_0001891 | D50 | 1 | 8 | 22 | 19 | 9 | 58 |
| Anemia | D000740 | EFO_0004272 | D64.9 | 1 | 2 | 19 | 19 | 3 | 44 |
| Iron deficiencies | D000090463 | E61.1 | 1 | 3 | 8 | 7 | 2 | 21 | |
| Heart failure | D006333 | EFO_0003144 | I50 | 1 | 1 | 6 | 9 | 2 | 19 |
| Inflammatory bowel diseases | D015212 | EFO_0003767 | — | 1 | 3 | 1 | — | 5 | |
| Restless legs syndrome | D012148 | EFO_0004270 | G25.81 | — | 3 | 1 | 1 | — | 5 |
| Neoplasms | D009369 | C80 | — | 2 | — | 1 | 1 | 4 | |
| Colorectal neoplasms | D015179 | — | 1 | — | 3 | — | 4 | ||
| Systolic heart failure | D054143 | EFO_1001207 | I50.20 | — | 1 | 1 | 2 | — | 4 |
| Replacement arthroplasty knee | D019645 | — | — | — | 2 | 1 | 3 |
Show 23 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Female genital neoplasms | D005833 | — | — | 1 | — | 1 | 2 | ||
| Pancreatic neoplasms | D010190 | EFO_0003860 | C25 | — | 1 | 1 | — | — | 2 |
| Breast neoplasms | D001943 | EFO_0003869 | C50 | — | — | 1 | — | — | 1 |
| Ductal carcinoma breast | D018270 | — | — | 1 | — | — | 1 | ||
| Inflammatory breast neoplasms | D058922 | — | — | 1 | — | — | 1 | ||
| Type 2 diabetes mellitus | D003924 | EFO_0001360 | E11 | — | — | 1 | — | — | 1 |
| Ulcerative colitis | D003093 | EFO_0000729 | K51 | — | — | 1 | — | — | 1 |
| Crohn disease | D003424 | EFO_0000384 | K50 | — | — | 1 | — | — | 1 |
| Atrial fibrillation | D001281 | EFO_0000275 | I48.0 | — | — | 1 | — | — | 1 |
| Cardiovascular diseases | D002318 | EFO_0000319 | I98 | — | — | 1 | — | — | 1 |
Show 6 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Pulmonary arterial hypertension | D000081029 | — | 1 | — | — | 1 | 2 | ||
| Gastrointestinal stromal tumors | D046152 | EFO_0000505 | C49.A | — | 1 | — | — | — | 1 |
| Chronic fatigue syndrome | D015673 | EFO_0004540 | G93.31 | — | 1 | — | — | — | 1 |
| Fibromyalgia | D005356 | EFO_0005687 | M79.1 | — | 1 | — | — | — | 1 |
| Thrombocytosis | D013922 | D75.83 | — | 1 | — | — | — | 1 |
Indications Phases 1
No data
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Scoliosis | D012600 | EFO_0004273 | M41 | — | — | — | — | 1 | 1 |
| Hemiarthroplasty | D062785 | — | — | — | — | 1 | 1 | ||
| Colonic neoplasms | D003110 | C18 | — | — | — | — | 1 | 1 | |
| Altitude sickness | D000532 | EFO_1000782 | T70.29 | — | — | — | — | 1 | 1 |
| Ventricular function | D016276 | — | — | — | — | 1 | 1 | ||
| Vaccine-preventable diseases | D000079263 | — | — | — | — | 1 | 1 | ||
| Cardiac arrhythmias | D001145 | EFO_0004269 | I49.9 | — | — | — | — | 1 | 1 |
| Myocardial infarction | D009203 | EFO_0000612 | I21 | — | — | — | — | 1 | 1 |
| Child development | D002657 | — | — | — | — | 1 | 1 | ||
| Neurodevelopmental disorders | D065886 | F89 | — | — | — | — | 1 | 1 |
Show 1 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | FERRIC CARBOXYMALTOSE |
| INN | ferric carboxymaltose |
| Description | Iron supplements, also known as iron salts and iron pills, are a number of iron formulations used to treat and prevent iron deficiency including iron deficiency anemia. For prevention they are only recommended in those with poor absorption, heavy menstrual periods, pregnancy, hemodialysis, or a diet low in iron. Prevention may also be used in low birth weight babies. They are taken by mouth, injection into a vein, or injection into a muscle. While benefits may be seen in days, up to two months may be required until iron levels return to normal.
|
| Classification | Unknown |
| Drug class | — |
| Image (chem structure or protein) | |
| Structure (InChI/SMILES or Protein Sequence) | — |
Identifiers
| PDB | — |
| CAS-ID | 9007-72-1 |
| RxCUI | — |
| ChEMBL ID | CHEMBL2108597 |
| ChEBI ID | — |
| PubChem CID | — |
| DrugBank | — |
| UNII ID | 6897GXD6OE (ChemIDplus, GSRS) |
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 1,795 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
5,282 adverse events reported
View more details
Premium feature
Learn more about premium features at pharmakb.com
Learn more